<DOC>
	<DOCNO>NCT00774943</DOCNO>
	<brief_summary>This Phase 1 , randomize , placebo-controlled , double-blind , dose-escalation study repeat SC dose AMG 557 adult Systemic Lupus Erythematosus .</brief_summary>
	<brief_title>A Study AMG 557 Adults With Systemic Lupus Erythematosus</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>Before studyspecific procedure , appropriate write informed consent must obtain ; Men woman , age 18 70 year old , inclusive , time randomization ; Diagnosis SLE define recent ACR criterion , include positive ANA screening document positive ANA ( titer least 1:80 ) past . SLE duration least six month , diagnose physician ; Stable disease , define change SLE therapy within previous 30 day ; , opinion investigator , anticipate need change SLE therapy require subject enrol study ; Normal clinically acceptable ECG ( 12lead report ventricular rate PR , QRS , QT , QTc ) screen Day 1 base opinion investigator ; Body mass index 18 40 kg/m2 screening ; Able willing complete entire study accord study schedule . Immunizations date , minimum tetanus , diphtheria , pertussis ( td/Tdap ) , pneumococcal ( polysaccharide ) influenza ( flu season ) vaccination , determine Principal Investigator . Positive serology HIV antibody , hepatitis B surface antigen hepatitis C antibody ( confirm PCR RIBA ) ; Have sign symptom viral , bacterial fungal infection within 30 day study randomization ; Evidence active latent tuberculosis assess PPD Quantiferon test screening ; Have donate blood experienced loss blood &gt; 500mL within 4 week randomization ; History ethanol drug abuse within last one year prior randomization ; Evidence significant renal insufficiency , define : The glomerular fitration rate &lt; 50 mL/min use Cockroft Gault equation ; Evidence liver disease ( eg , serum ALT AST &gt; 2x upper limit normal ) ; Total WBC &lt; 3000 x 106/L ; Neutrophil count &lt; 1500 x106/L Platelet count &lt; 75,000 x 106/L Hemoglobin &lt; 10g/dL Any disorder ( include psychiatric ) , condition clinically significant disease ( diagnosis SLE ) would , progressive nature and/or severity , interfere study evaluation , completion and/or procedures medical judgment investigator . This include age related comorbidites presence congestive heart failure , angina , chronic obstructive pulmonary disease , asthma , malignancy ( resect squamous basal cell carcinoma skin ) . Presence history vasculitis ( comprise internal organ extremity lead peripheral neuropathy ) within last 3 year , presence history active CNS lupus ( defined seizure disorder , cerebral vascular accident , psychosis ascribe SLE , encephalitis , meningitis , myelitis ) require therapy within last 3 year ; Uncontrolled hypertension ( Blood pressure &gt; 150/95 ) ; Poorly control diabetes ( HbA1c &gt; 8 % ) ; Any history granulomatous disease include autoimmune granulomatous vasculitis sarcoidosis ; Underlying condition predisposes subject infection ( eg , history splenectomy ) ; Any disorder condition prevents subject provide truly informed consent ; Prior administration biologic primarily target immune system ( eg , LymphostatB , TACIIg , CTLA4Ig ) past 9 month . This include prior administration AMG 557 ; Presence AMG 557 antibody ; Prior administration rituximab &gt; 9 month CD19+ B cell &lt; 5/ÂµL ; Administration cyclophosphamide ( alkylating agent ) , cyclosporine , tacrolimus , sirolimus , &gt; 100 mg/day prednisone equivalent 6 month prior randomization ; Participated investigational drug trial involve monoclonal antibody ( target immune system ) within 3 month 5 halflives , whichever time period longer , prior randomization ; Participated another investigational drug device trial within previous 30 day 5 halflives , whichever time period longer , prior randomization ; Administration &gt; 10 mg/day prednisone ( equivalent ) 30 day prior randomization ; Known sensitivity mammalian derive product ; Unwilling practice effective method doublebarrier contraception determine investigator duration study ; Positive serum hCG screen positive urine hCG D1 ; female currently lactate ; Known allergy shellfish excipients find KLH ; Previous immunization KLH .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Systemic lupus erythematosus</keyword>
	<keyword>ICOSL</keyword>
	<keyword>B7RP-1</keyword>
	<keyword>Costimulation</keyword>
</DOC>